Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP572002.RA0u8Md0teHXirKmYwzELQLG8W2lCptVZVrBWASYZIv5I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP572002.RA0u8Md0teHXirKmYwzELQLG8W2lCptVZVrBWASYZIv5I130_assertion type Assertion NP572002.RA0u8Md0teHXirKmYwzELQLG8W2lCptVZVrBWASYZIv5I130_head.
- NP572002.RA0u8Md0teHXirKmYwzELQLG8W2lCptVZVrBWASYZIv5I130_assertion description "[Anti-GOR was detected in serum from 59 (81%) of 73 patients with chronic NANBH, 40 (65%) of 62 with NANB liver cirrhosis, and 25 (63%) of 40 NANB patients with primary hepatocellular carcinoma, but in only less than 10% of patients with chronic liver diseases due to hepatitis B virus, alcohol, or an autoimmune disorder, and in only 2% of voluntary blood donors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP572002.RA0u8Md0teHXirKmYwzELQLG8W2lCptVZVrBWASYZIv5I130_provenance.
- NP572002.RA0u8Md0teHXirKmYwzELQLG8W2lCptVZVrBWASYZIv5I130_assertion evidence source_evidence_literature NP572002.RA0u8Md0teHXirKmYwzELQLG8W2lCptVZVrBWASYZIv5I130_provenance.
- NP572002.RA0u8Md0teHXirKmYwzELQLG8W2lCptVZVrBWASYZIv5I130_assertion SIO_000772 1701012 NP572002.RA0u8Md0teHXirKmYwzELQLG8W2lCptVZVrBWASYZIv5I130_provenance.
- NP572002.RA0u8Md0teHXirKmYwzELQLG8W2lCptVZVrBWASYZIv5I130_assertion wasDerivedFrom befree-2016 NP572002.RA0u8Md0teHXirKmYwzELQLG8W2lCptVZVrBWASYZIv5I130_provenance.
- NP572002.RA0u8Md0teHXirKmYwzELQLG8W2lCptVZVrBWASYZIv5I130_assertion wasGeneratedBy ECO_0000203 NP572002.RA0u8Md0teHXirKmYwzELQLG8W2lCptVZVrBWASYZIv5I130_provenance.